Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank67
3Y CAGR+63.1%
5Y CAGR+36.8%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+63.1%/yr
vs -28.2%/yr prior
5Y CAGR
+36.8%/yr
Recent acceleration
Acceleration
+91.3pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
4.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$5.43M-42.6%
2024$9.46M+10.8%
2023$8.54M+581.9%
2022$1.25M+1191.8%
2021$97000.00-91.4%
2020$1.13M-81.3%
2019$6.05M+28.2%
2018$4.72M+792.1%
2017$529000.00+713.8%
2016$65000.00-